FUJIFILM VisualSonics Named a Top Ten Visualization Solution Provider by Pharma Tech Outlook Magazine
TORONTO, March 21, 2018 /PRNewswire/ -- FUJIFILM VisualSonics Inc., a world leader in high frequency ultrasound imaging systems and subsidiary of FUJIFILM SonoSite, Inc., is recognized as one of the "Top 10 Visualization Solution Providers 2018" in Pharma Tech Outlook magazine's special edition of exceptional solutions providers that enable productive medical research.
"We are honored that our innovations have been recognized as a leader in the field by Pharma Tech Outlook," said Andrew Needles, director, marketing and product management at FUJIFILM VisualSonics, Inc. "Our ultra high frequency systems play a crucial role in developing lifesaving medical treatments by providing medical researchers with the tools needed to noninvasively screen and analyze preclinical models during the drug development process."
Following an analysis of 30 visualization solution provider companies, FUJIFILM VisualSonics Inc., was selected as a top company due to its trailblazing efforts to develop tools that are integrated, scalable and translatable for drug discovery and development.
The selection process of the "Top 10 Visualization Solution Providers 2018" includes nominations by Pharma Tech Outlook readers and research by the selection panel of top notch decision makers, including CEOs, CIOs and CTOs from the pharma and life sciences industry and Pharma Tech Outlook's editorial board.
In addition, FUJIFILM VisualSonics Inc. is the cover story of the special edition of Pharma Tech Outlook magazine which includes the "Top 10 Visualization Solution Providers 2018." The article is available online here: https://www.pharmatechoutlook.com/magazines/March2018/Visualization
Pharma Tech Outlook magazine is subscribed by over 36,000 qualified readers in the U.S. Pharma Tech Outlook has become a driving force for the various pharma and life sciences enterprises enabling them to move a step ahead and increase their return on investment by offering them a platform which can help them better understand the industry dynamics and advise the course of action.
About Fujifilm
FUJIFILM VisualSonics, Inc., is a global leader in real time, in vivo, ultra high frequency ultrasound and photoacoustic imaging systems. With headquarters in Toronto, Canada and offices around the world, FUJIFILM VisualSonics is represented globally across an integrated sales network. FUJIFILM VisualSonics is recognized worldwide for providing cutting edge imaging technologies for the advancement of preclinical research, particularly in cardiovascular, oncology, neurobiology and developmental biology areas. With the expansion of the product portfolio to include a new clinical product, FUJIFILM VisualSonics now broadens their range of imaging technologies across both preclinical and clinical markets. FUJIFILM VisualSonics is a subsidiary of FUJIFILM SonoSite, Inc. and a part of FUJIFILM Holdings Corporation. For more information, please go to: www.visualsonics.com
FUJIFILM SonoSite, Inc., is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. SonoSite's portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit: www.sonosite.com
FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation and leading-edge products to a broad spectrum of industries, including: healthcare, with medical systems, pharmaceuticals and cosmetics; graphic systems; highly functional materials, such as flat panel display materials; optical devices, such as broadcast and cinema lenses; digital imaging; and document products. These are based on a vast portfolio of chemical, mechanical, optical, electronic, software and production technologies. In the year ended March 31, 2017, the company had global revenues of $20.7 billion, at an exchange rate of 112 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com
All product and company names herein may be trademarks of their registered owners.
SOURCE FUJIFILM VisualSonics Inc.
Share this article